Form 4: Xylem Inc. Executive Michael McGann Reports Stock Transactions
SEC Form 4
Michael McGann, SVP & President Americas & MCS at Xylem Inc., reports acquisition and disposal of common stock and stock options related to vesting of performance-based stock units and tax liabilities.
Summary
- Michael McGann, a senior executive at Xylem Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 1, 2024, McGann acquired 501 shares of common stock upon vesting of performance-based stock units related to Total Shareholder Return at a price of $127.94.
- He also acquired 814 shares of common stock upon vesting of performance-based stock units related to ROIC at a price of $127.94.
- Additionally, McGann acquired 1,661 restricted stock units that will vest in increments on March 1, 2025, March 1, 2026 and March 1, 2027.
- He disposed of 610 shares to cover tax liabilities related to the vesting of performance-based stock units and 468 shares to cover tax liabilities related to restricted stock units, both at a price of $127.94.
- McGann was also granted 5,619 non-qualified stock options that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
- Following these transactions, McGann directly owns 4,020 shares of common stock and 5,619 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are routine and reflect standard executive compensation practices. The vesting of performance-based stock units suggests the achievement of certain performance targets.
Positives
- McGann's acquisition of shares upon vesting of performance-based stock units suggests the achievement of certain performance criteria related to Total Shareholder Return and ROIC.
- The grant of restricted stock units and stock options indicates continued alignment of McGann's interests with the long-term success of Xylem Inc.
Negatives
- The disposal of shares to cover tax liabilities, while a normal occurrence, slightly reduces McGann's direct ownership of Xylem Inc. stock.
Future Outlook
The restricted stock units and stock options granted to McGann will vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027, aligning his compensation with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the alignment of management's interests with those of shareholders. The vesting of performance-based stock units suggests that Xylem Inc. has met certain performance targets.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to incentivize performance and align management's interests with shareholders.
- The vesting schedules for the restricted stock units and stock options are typical for executive compensation packages, with vesting occurring over a period of several years.
- Companies like Danaher, Roper Technologies, and Advanced Drainage Systems also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices and alignment of management's interests with long-term company performance.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of the Amended and Restated Xylem Omnibus Incentive Plan. |
| 2021-03-01 | Date of grant of performance-based stock units and restricted stock units. |
| 2022-03-01 | Date of grant of restricted stock units. |
| 2023-03-01 | Date of grant of restricted stock units. |
| 2023-11-08 | Date of Power of Attorney. |
| 2024-03-01 | Date of transactions reported in Form 4, including vesting of stock units and grant of stock options and restricted stock units. |
| 2025-03-01 | First vesting date for restricted stock units and stock options. |
| 2026-03-01 | Second vesting date for restricted stock units and stock options. |
| 2027-03-01 | Third vesting date for restricted stock units and stock options. |
| 2034-03-01 | Expiration date for stock options. |
| 2024-03-05 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.